Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Treatment of acute leukemia with 5-azacytidine (NSC-102816).

× No keyword cloud information.

13 in total

Review 1. Inching toward cure of acute myeloid leukemia: a summary of the progress made in the last 50 years.

Authors: Peter H Wiernik
Journal: Med Oncol Date: 2014-07-22 Impact factor: 3.064

Review 2. Antineoplastic drugs: clinical pharmacology and therapeutic use.

Authors: R A Bender; L A Zwelling; J H Doroshow; G Y Locker; K R Hande; D S Murinson; M Cohen; C E Myers; B A Chabner
Journal: Drugs Date: 1978-07 Impact factor: 9.546

3. Cellular metabolism of 5,6-dihydro-5-azacytidine and its incorporation into DNA and RNA of human lymphoid cells CEM/O and CEM/dCk(-).

Authors: V I Avramis; W C Powell; R A Mecum
Journal: Cancer Chemother Pharmacol Date: 1989 Impact factor: 3.333

4. Epigenetic approaches in the treatment of myelodysplastic syndromes: clinical utility of azacitidine.

Authors: Steven E McCormack; Erica D Warlick
Journal: Onco Targets Ther Date: 2010-09-07 Impact factor: 4.147

5. Depression of experimental gastric ulcers and acute pancreatitis in rats treated by 5-azacytosine, 5-azacytidine and their N-methyl derivatives.

Authors: A Cihák; A Pískala; L Korbová; J Cízková; V Kucerová
Journal: Experientia Date: 1986-01-15

6. Azacitidine in the management of patients with myelodysplastic syndromes.

Authors: Cyrus Khan; Neeta Pathe; Salman Fazal; John Lister; James M Rossetti
Journal: Ther Adv Hematol Date: 2012-12

7. Biochemical pharmacology of 5,6-dihydro-5-azacytidine (DHAC) and DNA hypomethylation in tumor (L1210)-bearing mice.

Authors: W C Powell; V I Avramis
Journal: Cancer Chemother Pharmacol Date: 1988 Impact factor: 3.333

Review 8. Epigenetic therapies in MDS and AML.

Authors: Elizabeth A Griffiths; Steven D Gore
Journal: Adv Exp Med Biol Date: 2013 Impact factor: 2.622

9. Cellular metabolism of 1-beta-D-arabinofuranosyl-5-azacytosine and incorporation into DNA and RNA of human lymphoid CEM/0 and CEM/dCk(-) cells.

Authors: V I Avramis; W C Powell; R A Mecum
Journal: Cancer Chemother Pharmacol Date: 1989 Impact factor: 3.333

10. Arabinofuranosyl-5-azacytosine: activity against human tumors in athymic mice.

Authors: R E Wallace; D Lindh; F E Durr
Journal: Cancer Chemother Pharmacol Date: 1989 Impact factor: 3.333